Centrolateral Thalamic Nucleus is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The centrolateral thalamic nucleus (CL) is a key component of the intralaminar nuclear complex of the thalamus. It serves as a major relay for ascending arousal signals from the brainstem and plays critical roles in regulating consciousness, attention, and pain processing[1][2]. The CL is strategically positioned to integrate inputs from multiple sources, including the pedunculopontine nucleus, parabrachial nucleus, and cortical regions, making it essential for thalamocortical activation patterns underlying wakefulness and alert behavior[3]. [1]
The centrolateral nucleus is located in the medial thalamus, within the intralaminar complex that lies dorsal to the mediodorsal thalamic nucleus. It is composed of medium-sized neurons with extensive dendritic arborizations that receive convergent inputs from diverse brain regions[4]. The CL is divided into caudal and rostral subdivisions, each with distinct connectivity patterns and functional contributions. [2]
The CL projects densely to: [3]
CL neurons exhibit characteristic firing patterns that shift between states of burst and tonic activity. During wakefulness, tonic firing predominates, supporting sustained cortical activation. During non-REM sleep, burst firing becomes more prevalent, contributing to the synchronization of thalamocortical oscillations[15]. This gating mechanism is crucial for maintaining the balance between arousal and sleep. [4]
The CL is a critical driver of thalamocortical oscillations, particularly in the gamma frequency range (30-100 Hz) associated with focused attention and sensory processing[16]. Through its interactions with cortical pyramidal neurons and inhibitory interneurons, the CL helps coordinate the timing of neuronal ensembles necessary for cognitive functions. [5]
In Alzheimer's disease (AD), the centrolateral nucleus shows early pathological changes, including: [6]
CL dysfunction contributes to the characteristic attention and arousal disturbances seen in AD patients, including sundowning syndrome and disrupted sleep-wake cycles[20]. [7]
The centrolateral thalamic nucleus is implicated in Parkinson's disease (PD) through: [8]
Deep brain stimulation targeting the thalamus (including CL) has been used to treat tremor in PD, though the precise mechanisms remain under investigation[24]. [9]
In multiple system atrophy (MSA), the CL shows: [10]
CL pathology in progressive supranuclear palsy (PSP) includes: [11]
The centrolateral nucleus shows promise as a neuroimaging biomarker: [12]
The CL represents a potential therapeutic target for: [13]
Animal models: Rodent and non-human primate studies of thalamic circuitry[44]
In vitro models: Brain slice preparations for electrophysiology[45]
Computational models: Neural network simulations of thalamocortical dynamics[46]
Intralaminar Thalamic Nuclei
Thalamocortical Pathways
Arousal and Consciousness
Thalamic Stimulation
The study of Centrolateral Thalamic Nucleus has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development. [14]
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions. [15]
Additional evidence sources: [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45]
Jones EG. The Thalamus. 2007. ↩︎
Moruzzi G, Magoun HW. Brain stem reticular formation and activation of the EEG. 1949. ↩︎
Shermana SM. Thalamus. 2009. ↩︎
Garcia-Rill E. The pedunculopontine nucleus. 1991. ↩︎
Willis WD, Coggeshall RE. Sensory Mechanisms of the Spinal Cord. 1991. ↩︎
Goldman-Rakic PS, Porrino LJ. The primate mediodorsal (MD) thalamus and the prefrontal cortex. 1985. ↩︎
Parent A, Hazrati LN. Functional anatomy of the basal ganglia. 1995. ↩︎
Peyron C, Tighe DK, van den Pol AN, et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. 1998. ↩︎
Goldman-Rakic PS. Circuitry of the prefrontal cortex and the regulation of behavior by working memory. 1996. ↩︎
Culham JC, Valyear KF. Human parietal cortex in action. 2006. ↩︎
Haber SN, Calzavara R. The cortico-striatal circuitry. 2010. ↩︎
LeDoux JE. The emotional brain. 1996. ↩︎
Saper CB, Fuller PM, Pedersen NP, et al. Sleep state switching. 2010. ↩︎
McCormick DA, Bal T. Sleep and arousal: thalamocortical mechanisms. 1997. ↩︎
Singer W. Neuronal synchrony: a versatile code for the definition of relations? Neuron. 1999. ↩︎
Braak H, Alafuzoff I, Arzberger T, et al. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. 2006. ↩︎
Minoshima S, Giordani B, Berent S, et al. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. 1997. ↩︎
Zhou J, Greicius MD, Gennatas ED, et al. Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer's disease. 2010. ↩︎
Vitiello MV, Borson S. Sleep disturbances in patients with Alzheimer's disease: epidemiology, pathophysiology and treatment. 2001. ↩︎
Jellinger KA. The pedunculopontine nucleus in Parkinson's disease. 2008. ↩︎
Pahapill PA, Lozano AM. The pedunculopontine nucleus and Parkinson's disease. 2000. ↩︎
Kalia LV, Lang AE. Parkinson's disease. 2015. ↩︎
Benabid AL, Pollak P, Louveau A, et al. Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease. 1987. ↩︎
Gilman S, Koeppe RA, Chervin RD, et al. REM sleep behavior disorder is related to striatal monoaminergic deficit in MSA. 2003. ↩︎
Iranzo A, Santamaria J, Tolosa E. Idiopathic rapid eye movement sleep behavior disorder. 2009. ↩︎
Wenning GK, Tison F, Ben Shlomo Y, et al. Multiple system atrophy: a review of 203 pathologically proven cases. 1997. ↩︎
Hauw JJ, Daniel SE, Dickson D, et al. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). 1994. ↩︎
Litvan I. Progressive supranuclear palsy. 1998. ↩︎
Leigh RJ, Zee DS. The Neurology of Eye Movements. 2006. ↩︎
Callen DJ, Black SE, Gao F, et al. In vivo imaging of cortical lesions in subjects with Alzheimer's disease. 2001. ↩︎
Zhang Y, Schuff N, Du AT, et al. Diffusion tensor imaging of cingulate fibers in the brain in early Alzheimer's disease. 2009. ↩︎
Nordberg A, Rinne JO, Kadir A, et al. The use of PET in Alzheimer disease. 2010. ↩︎
Nadel L, Hardt O. Update on memory systems and processes. 2011. ↩︎
Schiff ND. Recovery of consciousness after brain injury: a mesocircuit hypothesis. 2010. ↩︎
Casey KL. Pain perception and ascending reticular formation. 1974. ↩︎
Fischl B, Dale AM. Measuring the thickness of the human cerebral cortex from magnetic resonance images. 2000. ↩︎
Buckner RL, Andrews-Hanna JR, Schacter DT. The brain's default network: anatomy, function, and relevance to disease. 2008. ↩︎
Klunk WE, Engler H, Nordberg A, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. 2004. ↩︎
Mori S, van Zijl PC. Fiber tracking: principles and strategies - a technical review. 2002. ↩︎
Jeanmonod D, Magnin M, Morel A. Thalamus and neurogenic pain. 1987. ↩︎
Halgren E, Baudena P, Clarke JM, et al. Intracerebral potentials to rare target and distractor auditory and visual stimuli. 1995. ↩︎
Polich J. Updating P300: an integrative theory of P3a and P3b. 2007. ↩︎
Purpura DP. Operations and processes in thalamic and synaptically related neuronal subsystems. 1970. ↩︎
Huguenard JP, McCormick DA. Electrophysiology of the neuron. 2009. ↩︎
Destexhe A, Sejnowski TJ. Thalamocortical Assemblies: How Ion Channels, Single Neurons, and Network Interactions Shape Cortical Activation. 2001. ↩︎